Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004138 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
A NA study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 303
- Enrollment target
- 20
- Study locations
NCT00004138: Completed NA study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
NCT00004138 is a NA study of Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 303 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004138, a NA study of Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Imaging procedures, such as positron emission tomography (PET), may improve the ability to detect the extent of non-small cell lung cancer. PURPOSE: Diagnostic trial to study the effectiveness of PET for detecting lesions in patients who have newly diagnosed stage I, stage II, or stage IIIA non-small cell lung cancer.
Conditions Studied
Interventions
- RADIATION fludeoxyglucose F 18
- PROCEDURE positron emission tomography
- PROCEDURE radionuclide imaging
Study Locations (20)
Pennsylvania
- Westmoreland Hospital - Greensburg
- Jameson Memorial Hospital - New Castle
- Allegheny General Hospital - Pittsburgh
- Western Pennsylvania Cancer Institute - Pittsburgh
California
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- UCSF Cancer Center and Cancer Research Institute - San Francisco
Florida
- Morton Plant Mease Health Care - Clearwater
- Lakeland Regional Medical Center - Lakeland
Illinois
- University of Chicago Cancer Research Center - Chicago
- Lutheran General Hospital - Park Ridge
Iowa
- Holden Comprehensive Cancer Center - Iowa City
- Veterans Affairs Medical Center - Iowa City - Iowa City
New York
- Memorial Sloan-Kettering Cancer Center - New York
- Mount Sinai School of Medicine - New York
Indiana
- Indiana University Cancer Center - Indianapolis
Maryland
- Marlene and Stewart Greenebaum Cancer Center, University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 1999-09 |
| Est. Completion | 2002-12 |
| Phase | NA |
What the finished NCT00004138 record still lists
NCT00004138 is an interventional study that assigns participants to a tested intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which fludeoxyglucose F 18 is the first listed.
NCT00004138 names 20 study sites across 12 states, led by Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00004138 about?
NCT00004138 is a clinical study titled "Positron Emission Tomography for Detecting Non-small Cell Lung Cancer". RATIONALE: Imaging procedures, such as positron emission tomography (PET), may improve the ability to detect the extent of non-small cell lung cancer. PURPOSE: Diagnostic trial to study the effectiveness of PET for detecting lesions in patients who have newly diagnosed stage I, stage II, or stage I...
What is the current status of trial NCT00004138?
This trial is currently completed. It is a NA study. The enrollment target is 303 participants. The study started on 1999-09. Estimated completion is 2002-12.
What conditions does trial NCT00004138 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00004138?
The interventions under investigation include: fludeoxyglucose F 18 (RADIATION), positron emission tomography (PROCEDURE), radionuclide imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00004138?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004138 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00004138's enrollment target sits among peer trials
303 98th of 409 higher than 312 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia